Goldline-Pharmaceutical (4)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Goldline Pharmaceutical Limited (ticker: 544759) will be added to the BSE SME IPO Index effective May 20, 2026, following its listing on BSE … | |||||||||||||||
Goldline Pharmaceutical Limited (ticker: 544759) will be added to the BSE SME IPO Index effective May 20, 2026, following its listing on BSE on May 19, 2026.
| |||||||||||||||
BSE notifies transfer of Goldline Pharmaceutical Limited SME IPO equity shares from Trade for Trade segment (MT Group) to Rolling segment (M … | |||||||||||||||
BSE notifies transfer of Goldline Pharmaceutical Limited SME IPO equity shares from Trade for Trade segment (MT Group) to Rolling segment (M Group) effective June 3, 2026.
| |||||||||||||||
Goldline Pharmaceutical Limited's equity shares will be listed on BSE SME platform effective May 19, 2026, in the 'MT' Group under … | |||||||||||||||
Goldline Pharmaceutical Limited's equity shares will be listed on BSE SME platform effective May 19, 2026, in the 'MT' Group under Trade-for-Trade segment for 10 trading days.
| |||||||||||||||
BSE notifies trading members that 7,32,000 equity shares of Goldline Pharmaceutical Limited have been allocated to Anchor Investors at Rs. … | |||||||||||||||
BSE notifies trading members that 7,32,000 equity shares of Goldline Pharmaceutical Limited have been allocated to Anchor Investors at Rs. 43 per share under its public issue.
| |||||||||||||||